myStoria Raises $1.6M Seed Round Led by Graphite Ventures
▼ Summary
– The startup myStoria has raised $1.625 million in a seed funding round led by Graphite Ventures.
– It addresses fragmented care in reproductive health, initially focusing on fertility and IVF before expanding to PCOS, endometriosis, and perimenopause.
– The platform uses a “Context Engine” to organize a patient’s complete health data and combines AI analysis with review by trained human professionals.
– Founder and CEO Jessica Chalk built the company based on her personal six-year, $100,000+ journey navigating infertility treatments.
– Investors describe the company as a defensible infrastructure play that aims to manage longitudinal health data for patients across complex care situations.
Navigating a complex health diagnosis often means patients are unexpectedly handed a second, unpaid job. They must become their own project manager, medical historian, and advocate, typically without any formal support or tools. Ontario-based startup myStoria is building the critical infrastructure designed specifically for that overwhelmed individual. The company has secured $1.625 million in a seed funding round to advance its mission, with Graphite Ventures leading the investment.
The funding round included participation from Conexus Venture Capital, Adrenaline Fund, Phoenix Fire Fund, and several strategic angel investors. myStoria initially focused on reproductive health, an area known for exceptionally long diagnostic delays and fragmented care pathways. Founder and CEO Jessica Chalk developed the platform based on her personal six-year journey through infertility, which involved multiple treatments costing over $100,000. She built the solution she needed but could not find.
This new capital will allow myStoria to expand its scope across the full reproductive health lifecycle. The platform will now provide support for conditions including PCOS, endometriosis, perimenopause, and broader hormonal health, each with tailored, condition-specific pathways. At its core, the service employs a human-in-the-loop model that combines artificial intelligence with trained professional review.
A proprietary layer called the Context Engine powers the platform. It organizes a user’s complete health picture, documents, audio notes, photos, symptom logs, and appointment history into a structured format optimized for AI. Every interaction builds upon this retained history, with professionals reviewing AI-generated guidance to add necessary clinical context. The goal is to deliver responses that are deeply personal, accurate, and grounded in a full health narrative rather than offering generic information.
Aaron Bast, a General Partner at lead investor Graphite Ventures, framed the opportunity as a fundamental infrastructure play. He emphasized that myStoria is not merely another consumer app but a defensible platform that owns the patient’s longitudinal health data. Graphite Ventures typically invests between $500,000 and $1.5 million in seed-stage B2B and digital health companies across Canada, placing the myStoria round at the top of that range.
Alex Shimla, Principal at Conexus Venture Capital, echoed this sentiment, stating the company is creating the patient-owned infrastructure the healthcare system has lacked. The platform is launching on iOS and Android under a freemium model, making its initial tools widely accessible.
The company’s long-term vision extends well beyond reproductive health. This initial focus serves as a strategic wedge into a model that could eventually assist patients managing cancer, heart disease, autoimmune conditions, and any complex care scenario where the individual is forced to become their own care coordinator.
(Source: The Next Web)
